APA (7th ed.) Citation

Rohr, B. S., Krohmer, E., Foerster, K., Burhenne, J., Schulz, M., Blank, A., . . . Haefeli, W. E. (2024). Time course of the interaction between oral short-term ritonavir therapy with three factor Xa inhibitors and the activity of CYP2D6, CYP2C19, and CYP3A4 in healthy volunteers. Clinical pharmacokinetics, 63(4), . https://doi.org/10.1007/s40262-024-01350-x

Chicago Style (17th ed.) Citation

Rohr, Brit Silja, Evelyn Krohmer, Kathrin Foerster, Jürgen Burhenne, Martin Schulz, Antje Blank, Gerd Mikus, and Walter E. Haefeli. "Time Course of the Interaction Between Oral Short-term Ritonavir Therapy with Three Factor Xa Inhibitors and the Activity of CYP2D6, CYP2C19, and CYP3A4 in Healthy Volunteers." Clinical Pharmacokinetics 63, no. 4 (2024). https://doi.org/10.1007/s40262-024-01350-x.

MLA (9th ed.) Citation

Rohr, Brit Silja, et al. "Time Course of the Interaction Between Oral Short-term Ritonavir Therapy with Three Factor Xa Inhibitors and the Activity of CYP2D6, CYP2C19, and CYP3A4 in Healthy Volunteers." Clinical Pharmacokinetics, vol. 63, no. 4, 2024, https://doi.org/10.1007/s40262-024-01350-x.